Tag:
Gattex
Latest Headlines
Latest Headlines
NPS Pharma shares sink after cancers reported in patients on bowel drug
NPS Pharmaceuticals gave investors a reason to run yesterday, but at least one analyst says today that the reaction was too much. The Bedminster, NJ-based developer said that three patients at sites
NPS soars on positive Ph3 data for orphan SBS drug
NPS Pharmaceuticals ( $NPSP ) says that it's on track to file for regulatory approval of Gattex after a late-stage study involving 86 patients demonstrated promising results for reducing the need for
